1,516 articles
Marc A. Pfeffer
Marc A. Pfeffer, born 1947, is an American cardiologist at Brigham and Women's Hospital and Harvard Medical School who led the SAVE trial of ACE inhibitors after myocardial infarction.
Marc C. Reitman
Marc C. Reitman, also known as Marc L. Reitman, is an American physician-scientist who studies energy homeostasis, metabolic rate, and body temperature at the NIH.
Marc Claret
Marc Claret is a scientist at IDIBAPS and Hospital Clínic de Barcelona who studies hypothalamic control of appetite and metabolism, known for a 2013 Cell paper on Mitofusin 2 and leptin resistance.
Marc P. Bonaca
Marc P. Bonaca is an American cardiologist and vascular medicine specialist who leads large clinical trials in atherosclerotic disease, including PEGASUS-TIMI 54 and VOYAGER PAD.
Marc Prentki
Marc Prentki is a Swiss-trained biochemist and professor at the Université de Montréal who founded the Montreal Diabetes Research Center and introduced the concept of glucolipotoxicity.
Marc S. Sabatine
Marc S. Sabatine is an American cardiologist who chairs the TIMI Study Group at Brigham and Women's Hospital in Boston and is a professor at Harvard Medical School.
Marc Wein
Marc Wein is an American physician-scientist at Harvard Medical School and Massachusetts General Hospital who studies bone biology and received a 2025 Presidential Early Career Award.
Marc Y. Donath
Marc Y. Donath (Marc Donath) is a Swiss endocrinologist who identified IL-1β-driven islet inflammation in type 2 diabetes and led the first trial blocking it.
Marcelo F. Di Carli
Marcelo F. Di Carli is an Argentine-born American nuclear cardiologist who directs cardiac imaging at Brigham and Women's Hospital and is a Professor of Radiology at Harvard Medical School.
Marco Metra
Marco Metra (born 1957) is an Italian cardiologist known for the RELAX-AHF serelaxin trials in acute heart failure and for co-chairing the 2021 ESC heart failure guidelines.
Marco Valgimigli
Marco Valgimigli, born 1972 in Forlì, Italy, is an Italian interventional cardiologist who led the MATRIX and MASTER DAPT trials, co-developed the PRECISE-DAPT score, and became Chief of Cardiology at Cardiocentro Ticino in Lugano in 2026.
Marcus Flather
Marcus Flather is a British cardiologist and clinical trials researcher, Emeritus Professor at the University of East Anglia, best known for leading the ART bypass surgery trial.
Marcus Lind
Marcus Lind is a Swedish professor of diabetology at the University of Gothenburg and chief physician at the NU Hospital Group in Uddevalla, known for studies of excess mortality in diabetes.
Margaret Grey
Margaret Grey is an American nurse scientist who studies self-management of chronic illness, especially type 1 diabetes in youth, and was dean of the Yale School of Nursing from 2005 to 2015.
Margaret M. Redfield
Margaret M. Redfield is an American cardiologist and physician-scientist at Mayo Clinic in Rochester, Minnesota, whose research has defined the epidemiology and treatment of HFpEF.
Maria Inês Schmidt
Maria Inês Schmidt is a Brazilian epidemiologist who spent her career at UFRGS in Porto Alegre, described the dawn phenomenon, and led the EBDG and ELSA-Brasil studies.
Mark A. Creager
Mark A. Creager is an American cardiologist and vascular medicine researcher at Dartmouth's Geisel School of Medicine who served as President of the American Heart Association.
Mark A. Sussman
Mark A. Sussman is an American cardiovascular molecular biologist, Distinguished Professor of Biology at San Diego State University, known for research on cardiomyocyte survival and cardiac regeneration.
Mark C. Petrie
Mark C. Petrie is a Scottish cardiologist and Professor of Cardiology at the University of Glasgow, known for heart failure research and the STEP-HFpEF semaglutide trial.
Mark E. Anderson
Mark E. Anderson is an American cardiac electrophysiologist and physician-scientist who became Dean of the Pritzker School of Medicine at the University of Chicago in 2022.
Mark E. Cooper
Mark E. Cooper, also known as Mark Cooper, is an Australian professor of diabetes at Monash University known for research on diabetic kidney disease and complications.
Mark E. Josephson
Mark E. Josephson (1943–2017) was an American cardiologist who pioneered clinical cardiac electrophysiology, standardized left ventricular mapping enabling catheter ablation of ventricular tachycardia, and led programs at Penn and Harvard's Beth Israel.
Mark E. Molitch
Mark E. Molitch is an American endocrinologist and Professor Emeritus of Medicine at Northwestern University Feinberg School of Medicine, known for research on pituitary tumors, prolactinomas, and diabetes.
Mark J Bolland
Mark J Bolland is a New Zealand endocrinologist and Associate Professor at the University of Auckland, known for trials and meta-analyses on calcium, vitamin D, and zoledronate.
Mark J. Caulfield
Sir Mark Caulfield is a British clinical pharmacologist at Queen Mary University of London who was Chief Scientist of Genomics England from 2013 to 2021.
Mark Levine (physician-scientist)
Mark Levine is an American physician-scientist who leads the Molecular and Clinical Nutrition Section at NIH, studying vitamin C needs and its intravenous use against cancer.
Mark R. Haussler
Mark R. Haussler is an American molecular endocrinologist at the University of Arizona known for identifying the renal vitamin D hormone and discovering the vitamin D receptor.
Mark Richards (cardiologist)
A. Mark Richards (Arthur Mark Richards) is a New Zealand cardiologist and professor at the University of Otago Christchurch, known for research that made NT-proBNP a global heart failure test.
Mark S. Link
Mark S. Link is an American cardiac electrophysiologist, Professor of Medicine and Director of Cardiac Electrophysiology at UT Southwestern Medical Center, known for his 1998 commotio cordis model.
Mark T. Keating
Mark T. Keating is an American molecular cardiologist who discovered the first arrhythmia genes and was elected to the National Academy of Sciences in 2004.